ArticleEnvironmental science & technology2025
Application of Toxicologically Informed Relative Potency Factors to Examine Associations between Water Disinfection Byproducts and Birth Defects.
Article in Environmental science & technology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
We used toxicologically informed relative potency factors (RPFs) to compare RPF-weighted versus unweighted epidemiologic analyses of five birth defects (atrial septal defect [ASD], ventricular septal defect [VSD], tetralogy of Fallot [TOF], cleft palate without cleft lip, and obstructive genitourinary defects [OGD]) and various disinfection byproduct (DBP) mixtures in drinking water. We derived RPFs for four trihalomethanes (THMs) and nine haloacetic acids (HAAs) from published animal developmental bioassays using benchmark dose models at 10% responses, estimated adjusted odds ratios (aORs) for RPF-weighted quintile 5 (vs 1) DBP mixture sums, and compared the RPF-weighted and unweighted aORs. RPFs were generally higher for brominated DBP species (e.g., HAA RPF10s from mouse whole embryo culture dysmorphogenesis data: monobromoacetic acid [MBAA] = 1.00, trichloroacetic acid [TCAA] = 0.0011, and dichloroacetic acid [DCAA] = 0.0005), which occurred at lower concentrations than chlorinated species. For THM mixtures, aORs changed <10% with RPF weighting, except for TOF (+19%) for the sum of brominated THMs (tribromomethane + bromodichloromethane + dibromochloromethane). We detected >10% aOR changes for HAA3 (TCAA + DCAA + dibromoacetic acid) with TOF and OGD; HAA5 (HAA3 + monochloroacetic acid + MBAA) with ASD, TOF, and OGD; HAA6 (all brominated HAAs) with TOF; and HAA9 (HAA5 + tribromoacetic acid + bromochloroacetic acid + bromodichloroacetic acid + dibromochloroacetic acid) with OGD. The results suggest that unweighted DBP metrics may reasonably estimate risks of regulated DBPs, but this should be examined elsewhere based on individual-level estimates, which should be prone to less exposure measurement error.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.